batanopride has been researched along with methylprednisolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Findlay, B; Kaizer, L; Laberge, F; Latreille, J; Lofters, WS; Osoba, D; Pater, J; Rusthoven, J; Warr, D; Wilson, K | 1 |
| Osoba, D; Pater, J; Rusthoven, J; Slamet, L; Warr, D; Zee, B | 1 |
1 review(s) available for batanopride and methylprednisolone
| Article | Year |
|---|---|
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1994 |
2 trial(s) available for batanopride and methylprednisolone
| Article | Year |
|---|---|
A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart; Humans; Hypotension; Life Tables; Male; Methylprednisolone; Metoclopramide; Multivariate Analysis; Serotonin Antagonists; Treatment Outcome; Vomiting | 1991 |
Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Male; Methylprednisolone; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prognosis; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 1994 |